Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Dow
Colorcon
Baxter
Harvard Business School

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VICKS FORMULA 44

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Vicks Formula 44

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000574 Ibuprofen in Sepsis Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1990-09-01 To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infection.
NCT00000574 Ibuprofen in Sepsis Study Completed Vanderbilt University Medical Center Phase 3 1990-09-01 To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infection.
NCT00000873 A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) N/A 1969-12-31 This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers.
NCT00000873 A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vicks Formula 44

Condition Name

Condition Name for Vicks Formula 44
Intervention Trials
HIV Infections 9
Obesity 8
Healthy 8
Anemia 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vicks Formula 44
Intervention Trials
Syndrome 25
Kidney Diseases 20
Diabetes Mellitus 17
Renal Insufficiency 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vicks Formula 44

Trials by Country

Trials by Country for Vicks Formula 44
Location Trials
United States 440
China 98
Italy 26
Canada 25
United Kingdom 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vicks Formula 44
Location Trials
New York 26
California 26
Texas 25
Maryland 24
Illinois 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vicks Formula 44

Clinical Trial Phase

Clinical Trial Phase for Vicks Formula 44
Clinical Trial Phase Trials
Phase 4 126
Phase 3 76
Phase 2/Phase 3 32
[disabled in preview] 118
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vicks Formula 44
Clinical Trial Phase Trials
Completed 252
Recruiting 123
Not yet recruiting 69
[disabled in preview] 53
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vicks Formula 44

Sponsor Name

Sponsor Name for Vicks Formula 44
Sponsor Trials
Hoosier Cancer Research Network 17
National Institute of Allergy and Infectious Diseases (NIAID) 11
Shanghai University of Traditional Chinese Medicine 9
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vicks Formula 44
Sponsor Trials
Other 786
Industry 160
NIH 54
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Mallinckrodt
Merck
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.